08:43 EDT MediWound (MDWD) down 8% at $16.50 following offering
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDWD:
- MediWound announces marketing approval of NexoBrid in Australia
- MediWound’s Earnings Call: Progress Amid Challenges
- MediWound Executives Purchase Shares, Signaling Confidence
- Promising Developments and Financial Stability Drive Buy Rating for MediWound
- Promising Developments and Strong Demand Drive Buy Rating for MediWound
